Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism

Journal of Clinical Investigation

Volumn 115, Issue 2, 2005, Pages 468-475

  Säemann, Marcus D ^a   Weichhart, Thomas ^b   Zeyda, Maximilian ^a   Staffler, Günther ^b,f   Schunn, Michael ^b   Stuhlmeier, Karl M ^c   Sobanov, Yuri ^d   Stulnig, Thomas M ^a   Akira, Shizuo ^e   Von Gabain, Alexander ^b   Von Ahsen, Uwe ^b,f   Hörl, Walter H ^a   Zlabinger, Gerhard J ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INTERCELL AG   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e OSAKA UNIVERSITY   (Japan)

^f Biovertis AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; TAMM HORSFALL GLYCOPROTEIN; TOLL LIKE RECEPTOR 4; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCOPROTEIN; TAMM-HORSFALL PROTEIN; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TLR9 PROTEIN, HUMAN; TLR9 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; KIDNEY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; URINALYSIS; URINARY TRACT; UROGENITAL TRACT DISEASE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; URINARY TRACT INFECTION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; KIDNEY; MACROPHAGES; MICE; MICE, KNOCKOUT; MUCOPROTEINS; NF-KAPPA B; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA; URINARY TRACT INFECTIONS;

EID: 20144373629     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200522720     Document Type: Article

References (51)

1. Pulendran, B., Palucka, K., and Banchereau, J. 2001. Sensing pathogens and tuning immune responses. Science. 293:253-256.
2. Janeway, C.A., Jr., and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
3. Takeda, K., Kaisho, T., and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
4. Akira, S., Takeda, K., and Kaisho, T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.
5. Zhang, D., et al. 2004. A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 303:1522-1526.
6. Jouault, T., et al. 2003. Candida albicans phospholipomannan is sensed through toll-like receptors. J. Infect. Dis. 188:165-172.
7. Gantner, B.N., Simmons, R.M., Canavera, S.J., Akira, S., and Underhill, D.M. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:1107-1117.
8. Brown, G.D., et al. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197:1119-1124.
9. Okamura, Y., et al. 2001. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:10229-10233.
10. Termeer, C., et al. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195:99-111.
11. Biragyn, A., et al. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 298:1025-1029.
12. Kopp, E., and Medzhitov, R. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15:396-401.
13. Serafini-Cessi, F., Malagolini, N., and Cavallone, D. 2003. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am. J. Kidney Dis. 42:658-676.
14. Thomas, D.B., Davies, M., and Williams, J.D. 1993. Tamm-Horsfall protein: an aetiological agent in tubulointerstitial disease? Exp. Nephrol. 1:281-284.
15. Kokot, F., and Dulawa, J. 2000. Tamm-Horsfall protein updated. Nephron. 85:97-102.
16. Mayrer, A.R., Miniter, P., and Andriole, V.T. 1983. Immunopathogenesis of chronic pyelonephritis. Am. J. Med. 75:59-70.
17. Khan, S.R., and Kok, D.J. 2004. Modulators of urinary stone formation. Front. Biosci. 9:1450-1482.
18. Su, S.J., Chang, K.L., Lin, T.M., Huang, Y.H., and Yeh, T.M. 1997. Uromodulin and Tamm-Horsfall protein induce human monocytes to secrete TNF and express tissue factor. J. Immunol. 158:3449-3456.
19. Kreft, B., et al. 2002. Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes. Infect. Immun. 70:2650-2656.
20. Mo, L., et al. 2004. Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am. J. Physiol. Renal Physiol. 286:F795-F802.
21. Bates, J.M., et al. 2004. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 65:791-797.
22. Weinstein, S.L., June, C.H., and DeFranco, A.L. 1993. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J. Immunol. 151:3829-3838.
23. Fontan, E., Jusforgues-Saklani, H., Briend, E., and Fauve, R.M. 1995. Purification of a 92 kDa human immunostimulating glycoprotein obtained from the Tamm-Horsfall glycoprotein. J. Immunol. Methods. 187:81-84.
24. Serafini-Cessi, F., Bellabarba, G., Malagolini, N., and Dall'Olio, F. 1989. Rapid isolation of Tamm-Horsfall glycoprotein (uromodulin) from human urine. J. Immunol. Methods. 120:185-189.
25. Ardeshna, K.M., Pizzey, A.R., Devereux, S., and Khwaja, A. 2000. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood. 96:1039-1046.
26. Ouaaz, F., Arron, J., Zheng, Y., Choi, Y., and Beg, A.A. 2002. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity. 16:257-270.
27. Janssens, S., and Beyaert, R. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell. 11:293-302.
28. Horng, T., Barton, G.M., and Medzhitov, R. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:835-841.
29. Lynn, K.L., et al. 1984. Antibodies to Tamm-Horsfall urinary glycoprotein in patients with urinary tract infection, reflux nephropathy, urinary obstruction and paraplegia. Contrib. Nephrol. 39:296-304.
30. Sandberg, T., and Fasth, A. 1987. Association between fever and the antibody response to Tamm-Horsfall protein in urinary tract infection. Scand. J. Urol. Nephrol. 21:297-300.
31. Hoyer, J.R. 1980. Tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein. Kidney Int. 17:284-292.
32. Mayrer, A.R., et al. 1982. Tubulointerstitial nephritis and immunologic responses to Tamm-Horsfall protein in rabbits challenged with homologous urine or Tamm-Horsfall protein. J. Immunol. 128:2634-2642.
33. Nagai, T. 1987. Tubulointerstitial nephritis by Tamm-Horsfall glycoprotein or egg white component. Nephron. 47:134-140.
34. Fasth, A., Hoyer, J.R., and Seiler, M.W. 1986. Renal tubular immune complex formation in mice immunized with Tamm-Horsfall protein. Am. J. Pathol. 125:555-562.
35. Ivanyi, B., Marcussen, N., Kemp, E., and Olsen, T.S. 1992. The distal nephron is preferentially infiltrated by inflammatory cells in acute interstitial nephritis. Virchows Arch., A, Pathol. Anat. Histopathol. 420:37-42.
36. Cavallone, D., Malagolini, N., and Serafini-Cessi, F. 1999. Binding of human neutrophils to cell-surface anchored Tamm-Horsfall glycoprotein in tubulointerstitial nephritis. Kidney Int. 55:1787-1799.
37. Fowler, J.E., Jr., Lynes, W.L., Lau, J.L., Ghosh, L., and Mounzer, A. 1988. Interstitial cystitis is associated with intraurothelial Tamm-Horsfall protein. J. Urol. 140:1385-1389.
38. Neal, D.E., Jr., Dilworth, J.P., and Kaack, M.B. 1991. Tamm-Horsfall autoantibodies in interstitial cystitis. J. Urol. 145:37-39.
39. Marier, R., et al. 1978. Antibody to Tamm-Horsfall protein in patients with urinary tract obstruction and vesicoureteral reflux. J. Infect. Dis. 138:781-790.
40. Fasth, A., Bengtsson, U., Kaijser, B., and Wieslander, J. 1981. Antibodies to Tamm-Horsfall protein associated with renal damage and urinary tract infections in adults. Kidney Int. 20:500-504.
41. Fasth, A., Bjure, J., Hjalmas, K., Jacobsson, B., and Jodal, U. 1984. Serum autoantibodies to Tamm-Horsfall protein and their relation to renal damage and glomerular filtration rate in children with urinary tract malformations. Contrib. Nephrol. 39:285-295.
42. Cohen, A.H., Border, W.A., Rajfer, J., Dumke, A., and Glassock, R.J. 1984. Interstitial Tamm-Horsfall protein in rejecting renal allografts. Identification and morphologic pattern of injury. Lab. Invest. 50:519-525.
43. Huang, Z.Q., Kirk, K.A., Connelly, K.G., and Sanders, P.W. 1993. Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation. J. Clin. Invest. 92:2975-2983.
44. Berke, E.S., Mayrer, A.R., Miniter, P., and Andriole, V.T. 1983. Tubulointerstitial nephritis in rabbits challenged with homologous Tamm-Horsfall protein: the role of endotoxin. Clin. Exp. Immunol. 53:562-572.
45. Tamm, I., and Horsfall, F.L. 1952. A mucoprotein derived from human urine which reacts with influenza, mumps and Newcastle disease virus. J. Exp. Med. 95:71-79.
46. Pak, J., Pu, Y., Zhang, Z.T., Hasty, D.L., and Wu, X.R. 2001. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin 1a and 1b receptors. J. Biol. Chem. 276:9924-9930.
47. Stöckl, J., et al. 1999. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J. Clin. Invest. 104:957-965.
48. Zeyda, M., et al. 2003. Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation. J. Immunol. 170:6033-6039.
49. Mechtcheriakova, D., et al. 2001. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J. 15:230-242.
50. Saemann, M.D., et al. 2002. Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. J. Leukoc. Biol. 71:238-246.
51. Stuhlmeier, K.M., Kao, J.J., and Bach, F.H. 1997. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappaB-alpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB. J. Biol. Chem. 272:24679-24683.